Coeptis Therapeutics Holdings, INC. (COEPW) — 10-K/A Filings

All 10-K/A filings from Coeptis Therapeutics Holdings, INC.. Browse 3 Amended Annual Report reports with AI-powered summaries and risk analysis.

10-K/A Filings (3)

Coeptis Files 10-K/A, Clarifies Warrant Terms on Nasdaq — Jun 3, 2025 Risk: low
Coeptis Therapeutics Holdings, Inc. (COEPW) filed a 10-K/A Amendment No. 1 for the fiscal year ended December 31, 2024, primarily to amend its annual report. Th
Coeptis Therapeutics Files 2023 10-K/A with Restated Financials — Aug 16, 2024 Risk: medium
Coeptis Therapeutics Holdings, Inc. filed an amendment (10-K/A) on August 16, 2024, for its fiscal year ending December 31, 2023. This filing includes restated
Coeptis Therapeutics Files 10-K/A Amendment to Restate 2022 Financials — Mar 25, 2024 Risk:
Coeptis Therapeutics Holdings, Inc. (COEPW) filed a Amended Annual Report (10-K/A) with the SEC on March 25, 2024. Coeptis Therapeutics Holdings, Inc. filed a 1

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX